IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development
- 1 December 2006
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 177 (11), 7898-7904
- https://doi.org/10.4049/jimmunol.177.11.7898
Abstract
Previous studies have shown that B cell development is blocked at the pre-B cell stage in IFN regulatory factor (IRF)4 (pip) and IRF8 (IFN consensus sequence binding protein) double mutant mice (IRF4,8−/−). In this study, the molecular mechanism by which IRF4,8 regulate pre-B cell development was further investigated. We show that IRF4,8 function in a B cell intrinsic manner to control pre-B cell development. IRF4,8−/− mice expressing a Bcl-2 transgene fail to rescue pre-B cell development, suggesting that the defect in B cell development in IRF4,8−/− mice is not due to a lack of survival signal. IRF4,8−/− pre-B cells display a high proliferation index that may indirectly inhibit the L chain rearrangement. However, forced cell cycle exit induced by IL-7 withdrawal fails to rescue the development of IRF4,8−/− pre-B cells, suggesting that cell cycle exit by itself is not sufficient to rescue the development of IRF4,8−/− pre-B cells and that IRF4,8 may directly regulate the activation of L chain loci. Using retroviral mediated gene transduction, we show that IRF4 and IRF8 function redundantly to promote pre-B cell maturation and the generation of IgM+ B cells. Molecular analysis indicates that IRF4, when expressed in IRF4,8−/− pre-B cells, induces κ germline transcription, enhances V(D)J rearrangement activity at the κ locus, and promotes L chain rearrangement and transcription. Chromatin immunoprecipitation assay further reveals that IRF4 expression leads to histone modifications and enhanced chromatin accessibility at the κ locus. Thus, IRF4,8 control pre-B cell development, at least in part, by promoting the activation of the κ locus.Keywords
This publication has 46 references indexed in Scilit:
- Epigenetic ontogeny of the Igk locus during B cell developmentNature Immunology, 2004
- Important Roles for E Protein Binding Sites within the Immunoglobulin κ Chain Intronic Enhancer in Activating Vκ Jκ
RearrangementThe Journal of Experimental Medicine, 2004
- Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2Blood, 2004
- Receptor Editing and Marginal Zone B Cell Development Are Regulated by the Helix-Loop-Helix Protein, E2AThe Journal of Experimental Medicine, 2004
- Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding ProteinThe Journal of Experimental Medicine, 1999
- In Vivo Occupancy of the κ Light Chain Enhancers in Primary Pro- and Pre-B Cells: A Model for κ Locus ActivationImmunity, 1997
- Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.Genes & Development, 1996
- The Igκ 3′ Enhancer Influences the Ratio of Igκ versus Igλ B LymphocytesImmunity, 1996
- A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient MiceImmunity, 1996
- Deletion of the Igκ Light Chain Intronic Enhancer/Matrix Attachment Region Impairs but Does Not Abolish VκJκ RearrangementImmunity, 1996